Evaluation of the quality of life in patients with meningiomas of the craniovertebral junction using a developed questionnaire in a neurosurgical clinic

Abstract

BACKGROUND: A validated tool for assessing the quality of life specific to a particular disease has not yet been developed. Previous studies only partially investigated the quality of life of patients with craniovertebral junction meningiomas and did not include the entire spectrum of functional disorders in this disease.

AIM: To develop and validate a questionnaire to assess the quality of life of patients with craniovertebral junction meningiomas.

MATERIALS AND METHODS: A retrospective and prospective study of 119 patients with craniovertebral junction meningiomas was conducted before and after surgical and combined (surgical removal of the tumor followed by radiation therapy) treatment using a validated questionnaire developed.

RESULTS: A quality of life questionnaire for patients with craniovertebral junction meningiomas was developed and validated. Determining the internal consistency of the scale showed that the Cronbach alpha coefficient was α=0.78 (p <0.001), confirming its sufficient level. In analyzing the sensitivity of the questionnaire, the estimates before and after surgery did not differ significantly (p=0.62, t-criterion).

CONCLUSIONS: This study developed the first quality of life questionnaire worldwide for patients with craniovertebral junction meningiomas. In summary, this questionnaire is not able to reflect the dynamics of the quality of life.

Keywords

meningioma / craniovertebral junction / quality of life / validation / skull base tumor / posterior fossa

References

[1] Arnautovic KI, Al-Mefty O, Husain M. Ventral foramen magnum meningiomas. Neurosurgery. 2000;92 Suppl 1:71–80. doi: 10.3171/spi.2000.92.1.0071

[2] Arnautovic K.I., Al-Mefty O., Husain M. Ventral foramen magnum meningiomas // Neurosurgery. 2000. Vol. 92 Suppl 1. Р. 71–80. doi: 10.3171/spi.2000.92.1.0071

[3] Fernandes MW, De Aguiar PH, Galafassi GZ, et al. Foramen magnum meningioma: Series of 20 cases. Complications, risk factors for relapse, and follow-up. Journal of Craniovertebral Junction and Spine. 2021;12(4):406–11. doi: 10.4103/jcvjs.jcvjs_58_21

[4] Fernandes M.W., De Aguiar P.H., Galafassi G.Z., et al. Foramen magnum meningioma: Series of 20 cases. Complications, risk factors for relapse, and follow-up // Journal of Craniovertebral Junction and Spine. 2021. Vol. 12, № 4. Р. 406–11. doi: 10.4103/jcvjs.jcvjs_58_21

[5] Paun L, Gondar R, Borrelli P, Meling TR. Foramen magnum meningiomas: a systematic review and meta-analysis. Neurosurgical Review. 2021;44(5):2583–2596. doi: 10.1007/s10143-021-01478-5

[6] Paun L., Gondar R., Borrelli P., Meling T.R. Foramen magnum meningiomas: a systematic review and meta-analysis // Neurosurgical Review. 2021. Vol. 44, № 5. Р. 2583–2596. doi: 10.1007/s10143-021-01478-5

[7] Pirotte BJ, Brotchi J, DeWitte O. Management of anterolateral foramen magnum meningiomas: surgical vs conservative decision making. Neurosurgery. 2010;67 Suppl 3:58–70. doi: 10.1227/01.NEU.0000382971.63877.DD

[8] Pirotte B.J., Brotchi J., DeWitte O. Management of anterolateral foramen magnum meningiomas: surgical vs conservative decision making // Neurosurgery. 2010. Vol. 67 Suppl 3. Р. 58–70. doi: 10.1227/01.NEU.0000382971.63877.DD

[9] Samii M, Klekamp J, Carvalho G. Surgical Results for Meningiomas of the Craniocervical Junction. Neurosurgery. 1996;39(6):1086–1095. doi: 10.1097/00006123-199612000-00003

[10] Samii M., Klekamp J., Carvalho G. Surgical Results for Meningiomas of the Craniocervical Junction // Neurosurgery. 1996. Vol. 39, № 6. Р. 1086–1095. doi: 10.1097/00006123-199612000-00003

[11] Nassiri F, Price B, Shehab A, et al.; International Consortium on Meningiomas. Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life. Neuro-Oncology. 2019;21 Suppl 1:32–43. doi: 10.1093/neuonc/noy152

[12] Nassiri F., Price B., Shehab A., et al.; International Consortium on Meningiomas. Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life // Neuro-Oncology. 2019. Vol. 21 Suppl 1. Р. 32–43. doi: 10.1093/neuonc/noy152

[13] Timmer M, Seibl-Leven M, Wittenstein K, et al. Long-Term Outcome and Health-Related Quality of Life of Elderly Patients After Meningioma Surgery. World Neurosurgery. 2019;125:697–710. doi: 10.1016/j.wneu.2019.01.158

[14] Timmer M., Seibl-Leven M., Wittenstein K., et al. Long-Term Outcome and Health-Related Quality of Life of Elderly Patients After Meningioma Surgery // World Neurosurgery. 2019. Vol. 125. Р. 697–710. doi: 10.1016/j.wneu.2019.01.158

[15] Wirsching HG, Morel C, Roth P, Weller M. Socioeconomic burden and quality of life in meningioma patients. Quality Life Research. 2020;29(7):1801–1808. doi: 10.1007/s11136-020-02461-1

[16] Wirsching H.G., Morel C., Roth P., Weller M. Socioeconomic burden and quality of life in meningioma patients // Quality Life Research. 2020. Vol. 29, № 7. Р. 1801–1808. doi: 10.1007/s11136-020-02461-1

[17] Shaffer BT, Cohen MS, Bigelow DC, Ruckenstein MJ. Validation of a disease-specific quality-of-life instrument for acoustic neuroma: the Penn Acoustic Neuroma Quality-of-Life Scale. Laryngoscope. 2010;120(8):1646–54. doi: 10.1002/lary.20988

[18] Shaffer B.T., Cohen M.S., Bigelow D.C., Ruckenstein M.J. Validation of a disease-specific quality-of-life instrument for acoustic neuroma: the Penn Acoustic Neuroma Quality-of-Life Scale // Laryngoscope. 2010. Vol. 120, № 8. Р. 1646–54. doi: 10.1002/lary.20988

[19] Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care. 1992;30(6):473–83.

[20] Ware J.E. Jr, Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection // Medical Care. 1992. Vol. 30, № 6. Р. 473–83.

[21] Raco A, Pesce A, Toccaceli G, et al. Quality of Life After Craniovertebral Junction Meningioma Resection: Shaping the Real Neurologic and Functional Expectancies About These Surgeries in a Contemporary Large Multicenter Experience. World Neurosurgery. 2018;110:583–591. doi: 10.1016/j.wneu.2017.05.177

[22] Raco A., Pesce A., Toccaceli G., et al. Quality of Life After Craniovertebral Junction Meningioma Resection: Shaping the Real Neurologic and Functional Expectancies About These Surgeries in a Contemporary Large Multicenter Experience // World Neurosurgery. 2018. Vol. 110. Р. 583–591. doi: 10.1016/j.wneu.2017.05.177

[23] Karnofsky DA, Burchenal JH. The evaluation of chemotherapeutic agents against neoplastic disease. Cancer research. 1948;8:388–389.

[24] Karnofsky D.A., Burchenal J.H. The evaluation of chemotherapeutic agents against neoplastic disease // Cancer research. 1948. Vol. 8. Р. 388–389.

[25] Escorpizo R, Stucki G, Cieza A, Davis K, Stumbo T, Riddle DL. Creating an interface between the International Classification of Functioning, Disability and Health and physical therapist practice. Physical Therapy. 2010;90(7):1053–63. doi: 10.2522/ptj.20090326

[26] Escorpizo R., Stucki G., Cieza A., Davis K., Stumbo T., Riddle D.L. Creating an interface between the International Classification of Functioning, Disability and Health and physical therapist practice // Physical Therapy. 2010. Vol. 90, № 7. Р. 1053–63. doi: 10.2522/ptj.20090326

[27] In J, Kang H, Kim JH, et al. Tips for troublesome sample-size calculation. Korean Journal Anesthesiology. 2020;73(2):114–120. doi: 10.4097/kja.19497

[28] In J., Kang H., Kim J.H., et al. Tips for troublesome sample-size calculation // Korean Journal Anesthesiology. 2020. Vol. 73, № 2. Р. 114–120. doi: 10.4097/kja.19497

[29] Keshwara SM, Gillespie CS, Mustafa MA, et al. Quality of life outcomes in incidental and operated meningiomas (QUALMS): a cross-sectional cohort study. Journal of Neuro-oncology. 2023;161(2):317–327. doi: 10.1007/s11060-022-04198-y

[30] Keshwara S.M., Gillespie C.S., Mustafa M.A., et al. Quality of life outcomes in incidental and operated meningiomas (QUALMS): a cross-sectional cohort study // Journal of Neuro-oncology. 2023. Vol. 161, № 2. Р. 317–327. doi: 10.1007/s11060-022-04198-y

[31] Likert R. A technique for the measurement of attitudes. Archives of Psychology. 1932;22(140):5–55.

[32] Likert R. A technique for the measurement of attitudes // Archives of Psychology. 1932. Vol. 22, № 140. Р. 5–55.

[33] Belova AN. Scales, tests and questionnaires in neurology and neurosurgery. Moscow: Practical Medicine; 2018. 696 р. (In Russ). EDN: LSYFLZ

[34] Белова А.Н. Шкалы, тесты и опросники в неврологии и нейрохирургии. Москва: Практическая медицина, 2018. 696 с. EDN: LSYFLZ

[35] Mehta GU, Zenonos G, Patibandla MR, et al. Outcomes of stereotactic radiosurgery for foramen magnum meningiomas: an international multicenter study. Journal Neurosurgery. 2018;129(2):383–389. doi: 10.3171/2017.3.JNS163008

[36] Mehta G.U., Zenonos G., Patibandla M.R., et al. Outcomes of stereotactic radiosurgery for foramen magnum meningiomas: an international multicenter study // Journal Neurosurgery. 2018. Vol. 129, № 2. Р. 383–389. doi: 10.3171/2017.3.JNS163008

RIGHTS & PERMISSIONS

Eco-Vector